Bank Of Montreal Deciphera Pharmaceuticals, Inc. Transaction History

Bank Of Montreal

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 02, 2023	BUY	$13.28 - $15.96 $1.22 Million - $1.47 Million	92,060 New	92,060 $1.3 Million
Q1 2023 Jun 13, 2024	BUY	$14.26 - $22.1 $2.41 Million - $3.74 Million	169,194 New	169,194 $2.61 Million
Q1 2022 May 12, 2022	SELL	$6.87 - $11.11 $76,428 - $123,598	-11,125 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$7.7 - $37.13 $85,662 - $413,071	11,125 New	11,125 $112,000
Q3 2021 Nov 12, 2021	SELL	$26.46 - $37.15 $1.03 Million - $1.45 Million	-39,102 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$32.73 - $47.95 $1.28 Million - $1.87 Million	39,102 New	39,102 $1.44 Million

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.